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INTRODUCTION 
Gloriosa superba is widely used as a medicinal 
plant & the alkaloid from plant are used in the treatment 
of gout .& rheumatism. Gloriosa superba rhizome 
which is perennial harb & important medicinal plant as 
a raw material for the collection of cochicine. The 
phytochemical constituent is useful in many ailments 
like cancer, malarial, gout, cholagouge, abortifacient in 
piles & constipation. The plant flowers are useful in 
religious functions & festivals. The tuber is widely used 
suicidal agent among men & womens in rural & interior 
areas. It is also used for homicide.  The tuber of the 
plants is used as antidote from ancient time in snake 
bite. The tuber is commonly placed on window sills to 
determine snake presence. Rhizome of Gloriosa superba 
Linn (Colchicine) shows enzyme inhibitory activity  
Extract of alcohol obtained from the Gloriosa superba 
rhizomes was investigated for enzyme inhibition 
activities. The crude & H2O were checked for 
lipo0xygenase, acetylcholineesterase, 
butyrylcholineesterase & uricase  activities. An 
extraordinary inhibition on lipo-oxygenase had been 
obtained. The maximum enzyme inhibition potency was 
expected by chloroform extract among the all tested 
extracts. The extract was obtained in 90% chloroform. 
The 60-70% inhibition was obtained for lipo-
oxygenase. The inhibition of activity was obtained 49-
69% for acetylcholinestrase & 10-33% for 
butyrylcholinesterase where uricase inhibitory activity 
is not found in extract. 
 
Figure 1: Natural plant Gloriosa superba in Himalaya 
ABSTRACT 
Gloriosa superba Linn. is an important medicinal plant ( Liliaceae). It is a semi-woody herbaceous branched climber reaching 
approximately 5 meters height, with brilliant wavy-edged yellow and red flowers 1. Being native form Indian especially 
Southern India it is known as glory lily and climbing lily- in English. In the world market glory lily considered as rich source of 
colchicines and gloriosine 4. The flower has analgesic, anti-inflammatory potential, antimicrobial, larvicidal potential, 
antipoxviral potential, antithrombotic potential, antitumor potential, enzyme inhibition potential, and also used in treatment of 
snake bite, Skin disease, respiratory disorders 5, 6, 7, 8, 9. Medicinal plants have been used as sources of medicine in virtually all 
cultures 10, 11. In recent years, there has been a gradual revival of interest in the use of medicinal plants in developing countries 
because herbal medicines have been reported safe and without any adverse side effect especially when compared with synthetic 
drugs. Thus a search for new drugs with better and cheaper substitutes from plant origin is a natural choice. The medicinal 
values of these plants lie in some chemical substances that produce a definite physiological action on human body 12. Different 
parts of G. superba have wide variety of uses especially in traditional system of medicine. The tuber is used for the treatment of 
bruises and sprains, colic, chronic ulcers, haemorrhoids, cancer, impotence, nocturnal seminal emission, and leprosy and also 
for including labour pains and abortions 13. Gloriosa superba also used in wounds, skin related problems, Fever, Inflammation, 
piles, blood disorders, Uterine contractions, General body toner, Poisoning 14, 15. Roots are acrid, anthelmintic, antipyretic, 
bitter, digestive, expectorant, highly poisonous and promoting expulsion of the placenta. Root paste is effective against 
paralysis, rheumatism, snake bite and insect bites 16. This plant has gained the importance in medicine in recent years for the 
production of colchicine in large scale 17. The aim of this study was to identify and determine the phytochemicals present in G. 
superba leaves, flowers, seeds and tubers. The main MeOH & dichloromethane extract were isolated and evaluated for 
anticancer activity. 
Keywords: Gloriosa superba, MeOH extract, CDCl2 Extract,  anticancer activity 
Shah et al                                    Journal of Drug Delivery & Therapeutics. 2015; 5(4):27-42 28 
© 2011-15, JDDT. All Rights Reserved                                      ISSN: 2250-1177                                    CODEN (USA): JDDTAO 
Analgesic & anti-inflammatory activities of 
hydroalcohalic extract from gloriosa superba:- 
Gloriosa superba has been widely utilized as 
phytochemical medicine & its alkaloids from plant 
(colchicines & Gloriosine) have been utilized in the 
treatment of rheumatism & gout. We investigated the 
anti-inflammatory & analgesic activities of extract had 
been checked by applying Eddy’s hot plate method & 
acetic acid induced writhing procedure. The anti-
inflammatory activity was checked by applying cotton 
wool granuloma model & carrageenan induced paw 
edema model. The % inhibition of writhes or % 
protection had been obtained to be 64.09%, 78.56% & 
81.45% for extract at a dose 100, 200 & 400 mg/kg 
body weight with respect to in the CH3COOH induced 
writhing method (P<0.01) when compared with control. 
The % increase in rxn time at 90 minuts were 21.02%, 
79.96% & 158.05% for extract at a dose of 100, 200 & 
400 mg/kg body weight with respect to  in Eddy’s hot 
plate procedure (P<0.01) when compared with control. 
The % inhibition of paw edema had been increased with 
time & gave max. effect at 2 hrs, then declined in case 
of st&ard extract 400 mg/kg body weights. Only the 
200 & 400 mg/kg body weight. Only the 200 & 400 
mg/kg body wt extracts exhibited important result 
(P<0.05) when compared with control.  
The rats exhibited 9.59%, 28.72% & 45.8% 
inhibition of granuloma mass formation. After the 7 
days treatment with 100, 200 & 400 mg/kg body weight 
of extract when compared with control (P<0.05) in 
cotton pellet granuloma. 
MATERIAL AND METHODS 
The rhizome of Gloriosa superba plant was 
collected from Himalaya region. The plant was identified 
& authenticated by botanist,, Department of Taxonomy, 
IIIM, Jammu. A voucher specimen is held in the 
institutional Herbarium. After authentification, rhizome 
portion was dried at room temperature until they were 
free from moisture & subjected to physical evaluation 
with different parameters. The factors which were used 
for evaluation are nature, odor, color, shape, size length 
& width, finally, rhizome portion was subjected to size 
reduction to get coarse powder & then passed through 
sieve no. 40 to get uniform powder. Then the uniform 
powder was subjected to st&ardization with different 
parameters. 
Chemical required: 
Growth medium (RPMI), Fetal calf serum (SIGMA), 
PBS (MERCK), Trypan blue, EtOH, Penicillin 
(SIGMA), Streptomycin (SIGMA), Trichloroacetic 
acid, Distilled water, Sodium Hydroxide, Tris-EDTA 
Buffer (Hi-Media), Sulphorhodamine (SIGMA), Tris 
Buffer (Hi-Media), Acetic acid (Rankem, Sodium 
Bicarbonat (Rankem), Mitomycin C (SIGMA), 
Paclitaxel (taxol) (SIGMA), 5-Flourouracil (SIGMA), 
Hydrochloric acid (Rankem, Isopropanol (SISCO), Tris 
Acetate-EDTA buffer. 
Apparatus: 
Tissue culture flask (NUNC), 96-well flat bottomed 
culture plates (NUNC) Micropipattes (Eppendorf), 1.5 
ml & 0.5 ml eppendorf, centrifuse tubes (Tarsons), 15 
ml centrifuse tubes (tarsons), 50 ml centrifuse tubes, 
sterile centrifuse tubes, Cryovials, Glass bottle to store 
media etc. (Schott Duran), Glass pipattes (Tarsons), 
Syringes (Dispo van). 
Instruments: 
Hemocytometer, Cryocontainers (Thermo Electron), 
Water bath (Genei), Filtration assembly (Millipore), 
Deep Freezer (Scien Temp), Mechanical shaker, 
Centrifuge, (Beckman), Autoclave, ELISA Reader 
(Tecan), Liquid Nitrogen Cylender, CO2 gas cylinder, 
CO2 gas cylinder, CO2 gas Incubator (Hera Cell) 
Reagents 
1) Incomplete growth medium: Prepare RPMI-1640 
with 2 mML glutamine medium or MEM in double 
distilled water. pH is adjusted to 7.2. add Pencillin (100 
unites/ml dissolved in PBS) & sterilize by filtering 
through 0.2 µm filters in sterile laminar flow. Store the 
media in refrigerator (2-8°C). 
2) Complete growth medium: contains 10% FCS & 
1% Penicillin. The amount of FCS may vary depending 
upon the requirements of cell lines used. Freezing 
medium for cryopreservation contains 20% FCS & 10% 
DMSO in growth medium (RPMI or MEM). 
3) Phosphate Buffer Saline (PBS): dissolve 9.6 gm/Lt. 
in distilled water. PBS is used to prepare solutions of 
Penicillin & Trypsin EDTA. 
4) Penicillin Solution: Dissolve 100 units/ml or 625 
µg/ml in PBS. Penicllin is mixed in RPMI Medium to 
avoid contamination. 
5) Gentamycin Solution: Dissolve 50 µg/ml in PBS. 
Gentamycin is added in the medium used in the 
preparation of dilutions of the test sample to avoid 
contamination. Because of plant extracts. 
6) Trypsin ETDA: 0.005 % trypsin & EDTA 
(Disodium Salt) are dissolved in PBS. Trypsin EDTA is 
used to detach the cell while sub-culturing & splitting 
the cell lines. 
7) TCA: 50% (w/v) TCA solution is prepared in double 
distilled water. TCA is used for fixing the culture cells 
before washing. 
8) Acetic acid: Prepare 1% in distilled water. Acetic 
acid is utilized to prepare  solution of SBR dye crystals 
& remove unbound dye from cells after staining. 
9) SRB Dye: Dissolve 0.4% in 1% acetic acid. SRB 
Dye is mainly used to stain the basic proteins of cancer 
cells fixed by 50% TCA. 
10) Tris buffer: 10 mM (pH 10.5). tris buffer is used to 
dissolve protein bound dye. 
11) Special Requirements: cell lines, test materials & a 
well equipped cell culture laboratory. 
 Extraction of plant material (Gloriosa Superba 
rhizomes) 
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         The Gloriosa superba rhizomes were prepared 
coarse powder in grinder. 1 kilogram of powdered plant 
substance had been divided into major 3 parts & extract 
of every part was made. The plant material was 
extracted with MeOH, Dichloromethane & Et acetate 
separately & labelled as GS-ME, GS-D, GS-E 
respectively. 
a) Preparation of Methanol Extract 
Dried plant material (50 mg) was placed in a conical 
flask submerged with MeOH for 24 hrs. after st&ing for 
24 hrs, the percolate was collected. It was filtered & 
filterate was concentrated on rotatory evaporator & 
dried & labeled as (GS-ME). The dried extract was 
transferred to a tared wide mouth container. 
b) Preparation of dichloromethane Extract 
Dried plant material (50 g) was placed in a conical flask 
submereged with dichloromethane for 24 hrs. after 
st&ing for long time, the percolate was collected. It was 
filtered. Then filterate was concentrated on rotary 
evaporator & dried & labeled as (GS-D). the dried 
extract was transferred to a tarred wide mouth 
container. 
Column Chromatography of Dichloromethane 
extract 
Slurry formation 
Dried dichloromethane extract 3.5 gram was taken. 
Slilica gel 60-120 mesh (3.5 gram) was added & drying 
at room temperature free flowing slurry. 
Packig of the column 
Weight of silica gel used (column):           35 gm 
Diameter of column used:                         5.5 cm 
Length of the column used:                      90 cm 
Elution of the column 
The column was first eluted with petroleum ether. After 
that the column was eluted with Et acetate, 
dichloromethane & MeOH fractions of 300 ml of each 
were collected & concentrated on Rota-vapor. Thin 
layer chromatography of fractions were done 
simultaneously by applying various developing solvents 
accoradingly in different proportions & the proportions 
were pooled on the basis of thin layer chromatographic 
pattern shown by them. 
Column Chromatography of first fraction: 
Amount of silica taken (to form slurry): 200 mg 
Wight of extract:                                      150 mg 
Amount of silica charged in column:      500 mg 
Dimensions of column used:                   
Length of column:                                    60 cm 
Breadth of column:                             2.0 cm 
 
Figure 2: Solvent evaporation apparatus 
50 fractions were collected from this column eluted first 
by using pet. Ether alone & further by Petrolium – ethyl 
acetate mixture (starting from 5% Et acetate to 50%) 
fractions 25-30 eluted using 30% Et acetate in 
petroleum ether gave a pure compound & was named 
GS-6. The structure of the compound was elucidated 
with the help of PCR. 
13
CNMR, MS & FTIR. 
COMPD (GS-6) 
Physical state:                It is pale yellow powdered 
compound 
Yield:                              50 mg 
Melting point:                 146°C 
Mass MS/MS:                 422 (M
+
 + Na) 
IR/KBr cm
-1
:                    3285.34, 2925.99, 99.1662.60,    
                                          1588.68, 1556.04,  
                                         1254.12, 12, 1048.83, 754.62 
[α]D                                 -143 CHCl3, c 0.1) 
Rf                                    0.51 
 
Figure 3: TLC PLATE OF GS-6
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Table 1: 
1
H NMR spectral data of GS-6 (CDCl3) 
S. No. Chemical shift (δ) Multiplicities of 
the Signals 
No of 
protons 
Coupling constant J(Hz) assignments 
1. 7.47 S 1 H - H8 
2. 7.33 D 1 H 10.66 H11 
3. 6.85 D 1 H 10.66 H12 
4. 6.76 D 1 H 6.38 NH 
5. 6.54 S 1 H - H4 
6 4.65 M 1 H - H7 
7. 4.01 S 3 H - C-3 OCH3 
8. 3.95 S 3 H - C-10 OCH3 
9. 3.91 S 3 H - C-1 OCH3 
10. 3.65 s  3 H - C-2 OCH3 
11. 2.53 M 1 H - H5 
12. 2.41 M 1 H - H5 
13. 2.29 M 1 H - H6 
14. 1.99 S 1 H - H14 
15 1.85 M 1 H - H6 
 
 
Table 2: 
13
C NMR spectral data of GS-6 (CDCl3) 
S. no Chemical shift DEPT Assignment 
1. 1 151.18 C C1 
2. 2 141.63 C C2 
3. 3 153.56 C C3 
4. 4 107.34 CH C4 
5. 5 134.12 C C4a 
6. 6 29.89 CH2 C5 
7. 7 36.54 CH2 C6 
8. 8 52.56 CH C7 
9. 9 152.37 C C7a 
10. 10 130.53 CH C8 
11. 11 179.58 C C9 
12. 12 164.03 C C10 
13. 13 112.97 CH C11 
14. 14 135.66 CH C12 
15. 15 136.93 C C12a 
16. 16 125.57 C C12b 
17. 17 170.17 C C13 
18. 18 22.83 CH3 C14 
19. 19 61.59 CH3 C-1 OCH3 
20. 20 61.42 CH3 C-2 OCH3 
21. 21 56.13 CH3 C-10 OCH3 
22. 22 56.44 CH3 C-3 OCH3 
 
 
The compound was characterized as colchicines. The 
structure of cholchine is shown below 
 
O
H3CO
H3CO
H3CO
OCH3
CH3COHN  
Colchicines 
g) Column chromatography of second fraction 
Amount of silica taken (to form slurry): 250 mg 
Wight of extract:                                    150 mg 
Amount of silica charged in column:      400 mg 
Dimensions of column used:                   
Length of column:                                    60 cm 
Breadth of column:                                   2.0 cm 
25 fraction were collected from this column eluted first 
by using petroleum ether alone & further by petroleum 
– Et acetate mixture (starting from 5% ethyl acetate to 
50%) fractions 20-27 eluted using 12% Et acetate in 
petroleum ether gave a pure compound & was named 
GS-3. The structure of compound was elucidated with 
the help of PMR, 
13
C NMR, MS & IR. 
COMPD (GS-3) 
Physical state:                colorless needle crystals. 
Yield:                              25 mg 
Melting point:                 136°C 
Mass MS/MS:                 437 (M
+
 + Na) 
IR/KBr cm
-1
:                    3414, 2936, 1637, 1617 
[α]D                                 -30 CHCl3, c 0.1) 
Rf                                    0.61 
 
Figure 4: TLC PLATE OF GS-3
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Table 3: 
1
H NMR spectral data of GS-3 (CDCl3) 
S. No. Chemical shift (δ) Multiplicities of 
the Signals 
No of 
protons 
Coupling 
constant J(Hz) 
Assignments 
1. 0.68 S 3 H - H18 
2. 0.82 D 3 H 6.7 H27 
3. 0.85 D 3 H 6.7 H26 
4. 0.92 T 3 H 7.4 H29 
5. 1.01 D 3 H 6.5 H21 
6 3.58 S 3 H - H19 
7. 5.36 M 1 H - H3 
8. 3.95 M 1 H - H6 
 
Table 4: 
13
C NMR spectral data of GS-3 (CDCl3) 
S. no Chemical shift DEPT Assignment 
1.  12.48 CH3 C29 
2.  12.60 CH3 C18 
3.  19.67 CH3 C21 
4.  20.02 CH3 C26 
5.  20.02 CH3 C27 
6.  20.45 CH3 C19 
7.  21.70 CH2 C11 
8.  23.67 CH2 C28 
9.  24.92 CH2 C15 
10.  26.67 CH2 C23 
11.  28.52 CH2 C16 
12.  29.55 CH C25 
13.  32.20 CH2 C2 
14.  32.51 CH2 C7 
15.  32.52 CH C8 
16.  34.55 CH2 C22 
17.  36.77 CH C20 
18.  37.11 C C10 
19.  37.88 CH2 C1 
20.  40.30 CH2 C12 
21.  42.93 CH2 C4 
22.  42.95 C C13 
23.  46.42 CH C24 
24.  50.74 CH C9 
25.  56.67 CH C17 
26.  57.37 CH C14 
27.  72.34 CH C3 
28.  117.06 CH C5 
29.  141.37 C C6 
 
 
The compound was characterized as colchicines. The 
structure of cholchine is shown below 
CH3
CH3
CH3
CH3
CH3
CH3 H
H H
H
OH  
β - Sitosterol 
h) Column chromatography of third fraction 
Amount of silica taken (to form slurry): 400 mg 
Wight of extract:                                    300 mg 
Amount of silica charged in column:      700 mg 
Dimensions of column used:                   
Length of column:                                    60 cm 
Breadth of column:                                   2.0 cm 
50 fractions were collected from this column eluted first 
by using petroleum ether alone & further by petroleum 
– Et acetate mixture (starting from 5% Et acetate to 
50%) fractions 24-34 eluted using 30 % Et acetate in 
petroleum ether gave a pure compound & was named 
GS-7. The structure of compound was elucidated with 
the help of PMR, 
13
C NMR, MS & IR & the compound 
was characterized as colchicines. 
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i) Flash Chromatography of MeOH: H2O Extract 
Slurry formation 
Dried MeOH : H2O extract 80 mg was taken. Silica gel 
200-400 mesh (80 gm) wa added in this & drying at 
room temperature. Free flowing slurry was obtained. 
Packing of the flash column 
Weight of the silica column               : 800 gm 
Diameter of column used                  : 13 cm 
Length of column used                      : 32 cm 
Elution of column 
The column was run in increasing order of polarity & 
small fractions (75 ml) each were collected & 
monitored on thin layer chromatography by proper 
solvent system first of all the column was run with pet. 
Ether (100%). 10 fractions of each 0f 75 ml were 
collected. No spot was visualized on TLC plate. Then 
column was run with increasing conc. (2.5% Et acetate 
in hexane). 30 fractions were taken & TLC was 
monitored. Then column was run with 5% Et acetat in 
hexane. 25 fractions had been taken. Again polarity had 
been increased upto 10% Et acetate in hexane. Now 
column had been run with DCM (dichloromethane). 45 
fractions had been taken. But there was no spot seen on 
thin layer chromatographic sheet. Then the column had 
been run with 2.5 % methanol in Dichloromethane.  
35 fractions had been collected. Fraction no 22 – 28 had 
given one spot on then layer chromatographic plate. The 
fractions were poured & concentrated on rotary 
evaporator. The compound isolated from these fractions 
had been submitted for PMR.  The compound was 
labaled as GS-21 characterized as 3-demethylcolchicine 
by PMR, 
13
C NMR, FT-IR & Mass spectroscopy. Now 
column had been eluted with 5% methanol in Di Chloro 
Methane & Thin layer chromatographic plat was 
monitored. Now polarity had been increased upto 7.5 % 
MeOH in dichloromethane. 49 fractions were collected. 
Fraction no. 40-45 gave a pure compound. These 
fractions had been pooled & concentrated on rotatory 
evaporator. The compound isolated from these fractions 
was labelled as GS-23 characterized as β-sitisterol-3-O-
β-D glucoside. The column had been eluted with 10% 
MeOH.in Di chloro methane. A mixture was obtained 
which was need to be purified. Finally column was 
eluted with MeOH alone. 
COMPD (GS-21) 
Physical state:                It is pale colored powdered 
compound 
Yield:                              35 mg 
Melting point:                 142°C 
Mass MS/MS:                 407 (M
+
 + Na) 
IR/KBr cm
-1
:                    3285.34, 2925.99, 1662.60,   
                                         1588.68, 1556.04,  
                                         1254.12, 12, 1048.83, 754.62 
[α]D                                  -143 CHCl3, c 0.1) 
Rf                                     0.47 
 
Figure 5: TLC Plate of GS-21
 
Table 5: 
1
H NMR spectral data of GS-21 (CDCl3) 
S. No. Chemical shift (δ) Multiplicities of 
the Signals 
No of 
protons 
Coupling constant 
J(Hz) 
assignments 
1. 7.49 S 1 H - H8 
2. 7.31 D 1 H 10.66 H11 
3. 6.85 D 1 H 10.66 H12 
4. 7.09 D 1 H 6.38 NH 
5. 6.59 S 1 H - H4 
6 4.65 M 1 H - H7 
7. 4.01 S 3 H - C-3 OCH3 
8. 3.95 S 3 H - C-10 OCH3 
9. 3.91 S 3 H - C-1 OCH3 
10. 3.65 s  3 H - C-2 OCH3 
11. 2.53 M 1 H - H5 
12. 2.41 M 1 H - H5 
13. 2.29 M 1 H - H6 
14. 1.99 S 1 H - H14 
15 1.85 M 1 H - H6 
 
Shah et al                                    Journal of Drug Delivery & Therapeutics. 2015; 5(4):27-42 33 
© 2011-15, JDDT. All Rights Reserved                                      ISSN: 2250-1177                                    CODEN (USA): JDDTAO 
Table 6: 
13
C NMR spectral data of GS-21 (CDCl3) 
S. no Chemical shift DEPT Assignment 
1.  150.27 C C1 
2.  139.24 C C2 
3.  149.99 C C3 
4.  110.41 CH C4 
5.  134.75 C C4a 
6.  29.47 CH2 C5 
7.  36.21 CH2 C6 
8.  52.84 CH3 C7 
9.  152.96 C C7a 
10.  179.57 CH C8 
11.  179.58 C C9 
12.  164.02 C C10 
13.  113.13 CH C11 
14.  135.66 CH C12 
15.  137.23 C C12a 
16.  124.77 C C12b 
17.  170.44 C C13 
18.  22.68 CH3 C14 
19.  61.41 CH3 C-1 OCH3 
20.  61.33 CH3 C-2 OCH3 
21.  56.13 CH3 C-10 OCH3 
 
The compound was characterized as colchicines. The 
structure of cholchine is shown below 
 
O
H3CO
H3CO
H3CO
OH
CH3COHN  
3 – Demethyl Colchicines 
COMPD (GS-23) 
Physical state:                amourphus white powder.. 
Yield:                              10 mg 
Melting point:                270 - 271°C 
IR/KBr cm
-1
:                    3400, 3044, 1646 
 
 
Figure 6: TLC Plate of GS-23 
1
H NMR 500 MHz of GS-23 (CDCl3) 
5.26 (1H, m, H-6), 5.08 (1 H, J¼ 7.7 Hz H-10) 4.59 (1 
H, dd J¼ 11.6 Hz, 2.1 Hz, H-60b), 4.47 (1 H, dd J¼ 
11.7 Hz 5.2 Hz H-60a), 4.32 (2 H, m J¼ H-30, H-40), 
4.10 (1 H, t J¼ 7.9 Hz H-20), 4.02 (1 H, m H-50), 3.08 
(1 H, m H-3), 0.91 (3 H, J¼ 6.4 Hz Me-21), 0.90 (3 H, s 
Me-10), 0.89 (3 H, t J¼ 7.3 Hz Me-29), 0.85 (3 H, d, J¼ 
6.8 Hz Me-10), 0.86 (3 H, d J¼ 6.9 Hz Me-27), 0.08 (3 
H, s Me-10). The compound isolated was characterized 
as beta-sitisterol-3-O-β-D-glucoside. 
CH3
CH3
CH3
CH3
CH3
CH3 H
H H
H
GLUO  
β-sitisterol-3-O-β-D-glucoside 
RESULTS AND DISCUSSION 
On column chromatography of 
dichloromethane extract of Gloriosa superba overall 
two compounds were isolated labelled as GS-6 & GS-3 
respectively. The yield of GS-6 & GS-3 was 260 mg & 
30 mg. the compounds had been characterized by 
1
H 
NMR, 
13
NMR, DEPT, Mass & IR. 
(1) Colchicine: structure of colchicine is given 
below 
O
H3CO
H3CO
H3CO
OCH3
CH3COHN  
Total no. of CH3, CH2, CH, C & Mass of the 
compound were found in agreement with the literature 
values. 
(2) β- sitosterol structure is given below 
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CH3
CH3
CH3
CH3
CH3
CH3 H
H H
H
OH  
22, 23-Dihydrostigmosterol, stigmast-5-en-3-ol 
Total no. of CH3, CH2, CH, C & Mass of the 
compound were found in agreement with the literature 
values. 
In case of β-sitosterol acetylation was done & a 
monoacetate was formed which confirm the presence of 
hydroxyl group. 
On flash chromatography of aqueous MeOH 
extract two compounds had been isolated labelled as 
GS-21 & GS-23 & Characterized by 
1
H NMR, 
13
NMR, 
DEPT, Mass & IR. The yield of compound was 35 mg 
& 10 mg respectively. Compounds had been 
characterized as 3-demethylcolchicine & beta-
sitosterol-3-O-beta-D-glucoside. 
 (3) 3-Demethyl Colchicine: structure of 
colchicine is given below 
O
H3CO
H3CO
H3CO
OH
CH3COHN  
Total no. of CH3, CH2, CH, C & Mass of the 
compound were found in agreement with the literature 
values. 
(4) β- sitosterol-3-O-β-D-glucoside structure is given 
below 
CH3
CH3
CH3
CH3
CH3
CH3 H
H H
H
GLUO  
22, 23-Dihydrostigmosterol, stigmast-5-en-3-ol 
glycoside 
Total no. of CH3, CH2, CH, C & Mass of the 
compound were found in agreement with the literature 
values. 
In case of β-sitosterol-3-O-β-D-glucoside acetylation 
was done & a monoacetate was formed which confirm 
the presence of hydroxyl group. 
Pharmacological activities 
The solvent extracts coded as GS-PE, GS-D, GS-MW, 
GS-6, GS-2 along with compound coded asGS-6 had 
been tested for antibacterial & antifungal activity. The 
samples had been tested against pathogens i. e. bacteria 
i.e. S. aureous, MRSA & P. aeruginosa & fungus i.e. C. 
albicans. A. fumigates, amphotericin-B had been used 
as a st&ard antifungal agent in this study.
 
Table 7: showing the antibacterial activity of the given samples. 
Plant code MIC (µg/ml) 
S. aureus ATCC MRSA 15187 P. aeruginosa 
GS-PE >256 >256 >256 
GS-D >256 >256 >256 
GS-MW >256 >256 >256 
GS-6 >256 >256 >256 
GS-2 >256 >256 >256 
Ciprofloxacin 0.25 16 0.03 
 
Table 8: showing the antifungal activity of the given samples 
Plant code MIC (µg/ml) 
C. albicans ATCC 90028 A. fumigatus LSI-II 
GS-PE >256 >256 
GS-D >256 >256 
GS-MW >256 >256 
GS-6 >256 >256 
GS-2 >256 >256 
Amphotericin-B 1 1 
 
Ciprofloxacin was used as standard antibacterial agent & amphotericin-B was used as standard antifungal agent. 
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Table 9: showing the Anti-inflamatory activity of GS-D (Dichloromethane extract) sample 
S. No. Group/Dose Animal 
Labelled 
Intial paw 
Vol. 
Uninjected 
paw vol. 
Injected 
paw vol. 
Oedema % I 
1.  GS-D 250 
mg/kg p.o. 
H 1.0 1.0 1.9 0.9  
 
 
45.35 
2.  B 1.0 1.0 2.0 1.0 
3.  T 1.0 1.0 2.0 1.0 
4.  NC 0.9 0.9 2.1 1.1 
                                                                  1.00±0.0250 
5.  STD (Ibu) 
100mg/kg p.o. 
H 1.1 1.1 1.9 0.8  
 
 
49.18 
6.  B 1.1 1.1 2.1 1.0 
7.  T 1.2 1.2 2.2 1.0 
8.  NC 1.0 1.0 1.9 0.9 
                                                                                      0.93±0.0666 
9.  control H 1.1 1.1 3.0 1.9  
 
 
- 
10.  B 1.1 1.1 2.9 1.8 
11.  T 0.9 0.9 2.7 1.8 
12.  NC 1.0 1.0 2.8 1.8 
                                                         1.83±0.0333 
 
Table 10: showing the Comparative analysis of anti-inflammatory activity 
S. No. Group Dose (mg/kg p.o.) %I@4
th
 hr 
   1. GS-D 250 mg/kg p.o. 250 45.35 
2. STD (Ibu) 100 mg/kg p.o. 100 49.18 
3. Control (Vehicle) - - 
 
Route of administration of test compound: 
Oral route was used for the study. 
Inference 
The result of the coded  material GS-D revealed it to 
possess 45.35% anti-inflammatory activity against 
carrageenan induced oedema in rats at a dose of 250 
mg/kg p.o. the values are highly important (P<0.05; 
student-Newman- Keuls test) in comparision to the 
vehicle control. The anti-inflammatory activity of the 
compound was comparable to the standard drug 
Ibuprofen. 
Anti-Cancer Activity 
Human cancer cell lines: 
The cancer cell lines of different tissue origin available 
at IIM, Jammu for in vitro cytotoxicity  testing are as 
follows:- 
BREAST                    :          MCF-7 
CERVIX                     :          HeLa, SiHa 
CNS                           :          IMR-32, SK-N-SH, SNB-
78, SF-295 
COLON                      :         CoLo-205, HCT-15, HT-
29, SW-620, 502713 
LUEKEMIA                :          K-562, MOLT-4 
LIVER                        :          Hep-2 
LUNG                         :          A-549, MOLT-4 
PROSTATE               :          DU-145, PC-3 
ORAL                         :         KB 
 
Sources of cell lines: 
 National center for Cell Science, Ganeshkhind, 
Pune-4111007 (India). 
 National Cancer Institute, Biological Testing 
Branch DTP/DCTD/NCI, Federick Cancer 
Research & Development Center, Fairview, Suite 
205, 1003 West 7
th
 Street, Frederick, MD 21701-
8527 (USA) 
In-vitro anti-cancer studies 
Selection of cell lines: 
For primary screening, cell lines representing different 
types of human cancer & tissues are utilized. The cell 
lines are selected in such a way that all the cell lines 
grow in growth medium (RPMI & MEM) in tissue 
culture plates & mass doubling time in such that enough 
cells are obtained for screening. It is best to use these 
cell lines although others can be used. Cells to be 
utilized must be free from bacteria, yeast, moulds, 
mycoplasma & in certain cases, from viruses, at all the 
stages. If at any stages contamination appears, the stock 
in which it occurs must discarded immediately.
 
 
 
 
 
Shah et al                                    Journal of Drug Delivery & Therapeutics. 2015; 5(4):27-42 36 
© 2011-15, JDDT. All Rights Reserved                                      ISSN: 2250-1177                                    CODEN (USA): JDDTAO 
Table 11: In Vitro Anti-tumor activity 
S. No. Name ofcell lines Medium growth Positive control Source 
1.  502713 RPMI 5-flourouracil Colon 
2.  Colo 205 RPMI 5-flourouracil Colon 
3.  A-549 RPMI DDP, taxol Lung 
4.  HeLa RPMI DDP, 5-flourouracil Cervix 
5.  Hep-2 MEM DDP, Mitomycin-C Liver 
6.  HCT-15 RPMI 5-flourouracil Colon 
7.  SiHa RPMI DDP, 5-Fluorouracil Cervix 
8.  MOLT-4 RPMI Adiriamycin Leukemia 
9.  HT-29 RPMI 5-flourouracil Colon 
10.  IMR-32 RPMI Adriamycin, Vincristine CNS 
11.  K-562 MEM Adriamycin, Vincristine Leukemia 
12.  MCF-7 RPMI Adriamycin Breast  
 
Healing of cell lines on arrival: 
 Immediately on receipt of the original stock of cell 
lines from authentic source, the cells are observed 
under microscope, for apparent contamination & 
proper growth. If there is any contamination, the 
cell lines are discarded & fresh one is obtained 
 If it is observed under microscope that cells have 
been detached themselves from the flask & 
monolayer is not present the cells are removed, by 
taking out growth medium aseptically, centrifuged 
& then the cells are suspended in enough growth 
medium & incubated in carbon dioxide incubator to 
grow. 
 If there is a proper growth & monolayer is present, 
excess growth medium is colledctd aseptically in 
sterilized bottles which can be utilized again & the 
cells are incubated at 37°Cin atmoshphere of 5% 
CO2 & 90% Relative humidity, in CO2 incubator. 
The flask is checked daily for proper growth & 
complete growth medium (prewarmed at 37°C) is 
changed  whenever necessary. When growth is 70-
90% (sub-confluent) the passage is given 
Revival & seeding of cells: 
 Remove the desired cryovial from liquid nitrogen 
& thaw it to 37°C as soon as possible. 
 Wipe the cryovial with 70% alcohol before taking 
to laminar flow to avoid contamination. 
 Pour nearly 10 ml of complete growth medium to 
tissue culture flask. 
 Mix the cells in the cryovial properly & aspirate 
them with the help of an autoclaved syringes tip. 
 Add the cells to tissue culture flask & rinse the 
cryovial with media & add tissue culture flask. 
 Mix properly to ensure uniform distribution of cells 
in the growth medium. 
 Mark the flask properly & incubate it at 37°C, 5% 
carbon di oxide atmosphere & 90% humidity. 
 
Stages of cell growth during culturing: 
 Attachment Stage: within 24 hrs of incubation 
after seeding or trypsinization, the cells get 
attached to the base of tissue culture flask. 
 Sub-confluent Stage: It is a stage of rapid growth 
of cells. In this stage, some space remains in 
between the growing cells. The cells are in log 
phase of their growth & are used for experimental 
purposes. 
 Confluent Stage: The medium turns turbid as 
nutrients are utilized & cell derbis & metabolic 
wastes accumulate in the medium. When the cells 
are observed under microscope, they are found to 
form a complete monolayer. 
Maintenance of cell lines: 
The cell lines should be observed daily. If medium has 
become turbid, it should be changed. It helps to avoid 
contamination. Procedure for changing the medium is: 
Sub-culturing of cell lines: 
Sub-culturing of cell lines has been done by 
trypsinisation to maintain the cells in log phase of 
growth. The cells are detached when they reach 
confluent stage & to make single cell suspension for 
experimental purposes. The trypsinisation of a cell line 
should not be done more than 5 times as the cells lose 
their potential to grow. 
Crypreservation of the cells: 
 Take the flasks, which have the cells in log phase 
of growth. 
 The cells are trypsinized as usual. 
 Prepare the single cell suspension by passing the 
cells through pipatte. 
 Pour the cell suspension in sterilized centrifuge 
tubes & centrifuge at 2000 rpm for 10 minutes at 
0°C. 
 Remove the supernantant. 
 Add the freezing medium to the pellet & make 
single cell suspension by pipetting. 
 Pour the single cell suspension in cryovials upto 
2/3 of their volume. 
 Cryovials are stored in cryocontainer (having 
isopropanol to avoid sudden drop in temperature 
which may damage the cells) 
 Store the dryocontainers at -85°C in deep freezer. 
Preparation of test material: 
 Stock solution: prepare a stock solution of 20 
mg/ml. DMSO is used for dissolving 95% 
MeOH/EtOH extract, 50 % aqueous MeOH/EtOH 
extracts & distilled water for hot water extracts. 
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Stock solutions are prepared one day in advance. 
The working solutions of test samples are prepared 
in the complete growth medium. The samples, 
which do not dissolve properly, are kept in hot 
water hath at 50°C. the solution of test sample is 
prepared twice concentrated 1 of media. Hence the 
final than the final concentration as it is added to 
100 concentration is reduced to half of the intial 
concentration. Gentamycin (50 g/ml) is added to 
check the microbial contamination in growth 
medium. 
 Positive control: it is essential for comparision of 
the activity of the test material. Some of the 
compounds, which are generally used as positive 
control, are 
 5-fluorouracil: it is a prodrug undergoing a series 
of biotransformation reactions to ribosyl & 
desoxyribosyl nucleotide metabolites. One of these 
metabolites is 5-fluor-2-deoxyribosyl nucleotide 
metabolites. (FdUMP) which gets incoroporated in 
to RNA where it interferes with t-RNA & m-RNA 
translation. 
 Mitomycine-C: It is an antibiotic isolated from 
Streptomyces caespitosus. It is an alkylating agent 
that undergoes metabolic activation through an 
enzyme-mediated reduction, to generate an 
alkylating agent that cross-links DNA. 
 Blank control: Blank control is essential to reduce 
the OD of medium & test samples. In each plate 5-
8 wells of each row are blank control. In blank 
control, gentamycin media & test sample solution 
are added but cell suspension is not added. 
Determination of cytotoxicity: 
In a single 96 well plate, the cytotoxicity of sample can 
be determined on 2 cell lines at a time. The number of 
plates depends on the number of test samples. 
Preparation of cell suspension for the assay: 
The desired human cancer cell lines are grown in tissue 
culture flask at 37°C, in an atmosphere of 5% carbon di 
oxide & 90% relative humidity in complete growth 
medium to obtain enough number of cells. 
The wells of 1 to 4 & 9 to 12 of first row in each plate is 
control growth (CG) i.e. having the cell suspension & 
medium. The growth of the cells in these wells is the 
maximum as no test sample is added. 
The second row of one plate have 100 miroliter positive 
control (PC) i.e. having 5-FU of Mitimycin-C etc. the 
growth of these wells is less, as it is less, as it is the 
known inhibitor of cells. 
Addition of test material: 
 Incubate the plates for 48 hrs at 37 degree 
centigrade in an atmosphere of 5% CO2 & 90% 
relative humidity. 
 Determine the cell growth after 48 hrs of adding 
sample. 
Cytotoxicity assay by Sulphorhodamine B Dye: 
SRB assay is a rapid, sensitive & expenxive method for 
measuring the cytotoxity potential of test substances, 
based on the cellular protein content of adhered 
suspension cultures in 96 well plates. This method is 
suitable for ordinary laboratory purposes & for large-
scale applications like high throughput screening in 
anti-tumor drug development. 
Procedure of assay: 
 The plates are taken out from the incubator after 48 
hrs of adding test samples. 
 To stop the reaction, gently add 50 µl of chilled 
50% TCA (trichloroacetic acid) to each well of the 
plate, making final concentration of 10%. 
 Incubate the plates at 4°C for one hour to fix the 
cells attached to bottom of the wells. 
 Wash the plates 5-6 times with distilled water. 
 Plates are air-dried. 
 Add 100 µl of SRB dye (0.4% in 1% acetate acid) 
to each well of the plate & leave the isolates at 
room temperature for 30 minutes. 
 With the plates with 1% acetic acid after 30 
minutes. 
 Plates the again air-dried. 
 Add 100 µl of tris buffer (10.5 M) to each well. 
 Shake the plates gently for 10-15 minutes on a 
mechanical shaker. 
 Record the optical density with ELISA reader at 
540 nm wavelength & maintain the data. 
CALCULATIONS: 
The viability & growth in the presence of test material 
is calculated as: 
OD Change = Mean of OD of Test sample – mean of 
OD of Blank 
% Growth in presence of the Control = 100 / OD 
change in presence of control 
% Growth in the presence of Test sample = 
 (% growth of in presence of control) × (OD change in 
presence of test sample)
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Table 12: In vitro cytotoxicity report 
Tissue Lung Ovary Leukemia Prostate Breast Liver  
Cell line type A-549 IGR-OV-1 THP-1 PC-3 MCF-7 HEP-2 
CCL 
codes 
Inst. Codes Conc.  
% Growth Inhibition 
M-3824 GS-6 10µM       
  30µM 48 67 90 67 80 90 
  100µM 58 70 91 69 96 93 
 Paclitaxel 10µM 70 76 91 74 99 95 
 Mitomycin 10µM 69 59     
 5-FU 20µM    61   
 Adriamycin 1µM   75  76 72 
 
Quantification of colchicines by HPTLC 
In order to quantify colchicines content in the extract in 
the extracts prepared by using different solvents, it was 
envisaged to use High Performance Thin Layer 
Chromatography (HPTLC) procedure to achieve the 
objective. In this direction, 10 mg of each extract (five 
extracts in all) were taken & dissolve in 1 ml of MeOH 
.or MeOH/H2O samples were coded as I-0770-(01). I-
0770 (02), I-0770 (03), I-0770 (04), I-0770 (05) 20 mg 
of colchicines was taken as the st&ard sample & 
dissolved in 1 ml MeOH. St&ard curve was achieved 
with r squar = 0.99080125, an aliquot of 2 µl of each 
extract was charged on the TLC plate & the plate was 
analyzed for colchicines content. The % of colchicines 
in each extract was calculated using the following 
procedure. 
1. from HPTLC it was detected that the content of 
colchicnes in petroleum either extract I-0770-(01) was 
below detection limit (BDL). 
2. Calculation of content of colchicines in DCM extract-
I-0770-(02) 
2 µl of DCM extract showed presence of = 321.16 mg 
of colchine 
1000 µl contained colchicines = 321.16 × 500 = 
1600580 ng of colchicines. 
1 ml of DCM extract contained colchicines = 160580 ng 
of colchine. 
10 mg extract contains = 0.160580 mg of colchicines  
Therefore 35000 mg contains = 0.160580 × 3500 = 
562.03 mg 
3. calculation of content of colchicines in MeOH: water 
extact I-0770-(03) 
Each 2 microliter injection of sample name I-0770 (03) 
contains <90 mg of colchicines 
So 1000 µl contains colchicines = 90 × 500 = 45000 ng 
of colchicines. 
I ml of MeOH water extract contains colchicines = 
45000 ng 
10 mg of extract contains colchicines = 0.045 mg 
Therefore 80 mg contains colchicines. 
10 mg of this extract gives colchine = 0.045 mg 
80000 mg gives = 0.45 × 8000 = 360 mg 
4. Calculation of content of colchicines in sample name 
I-0770- (04) Et acetate extract each 2 µl injection 
contains colchicines = 231.77 mg of colchicines 
1 ml contains colchicines = 115885 ng 
10 mg of extract contains colchicines = 0.115885 mg 
Therefore 520 mg contains colchicines = 520 × 
0.115885 = 6.0262 mg 
Total quantity of colchicines in all extracts = 562.03 + 
360 + 6.0262 = 598.632mg 
1050 mg powdered plant material gives colchicines = 
0.59863262 mg 
1 gm powdered plant material gives colchicines = 
5.9863262/1050 = 0.000570126 gm 
100 gm gives = 0.000570126 × 100 = 0.0570126 
So the content of colchicines in whole plant = 
0.0570126% 
 
Table 13: HPTLC Result 
Sample name Colchicines 
I-0770-(01) (GS-PE) BDL 
I-0770 (02) (GS-D) 321.16 ng 
I-0770 (03) (GS-E) < 90 
I-0770 (04)(GS-ME) 231.77 ng 
I-0770 (05) (GS-MW) 174.57 ng 
 
Shah et al                                    Journal of Drug Delivery & Therapeutics. 2015; 5(4):27-42 39 
© 2011-15, JDDT. All Rights Reserved                                      ISSN: 2250-1177                                    CODEN (USA): JDDTAO 
 
Figure 7: HPTLC graph of Trace 1-4 
Light yellowish needle shaped crystalline compound (30 
mg) isolated from chloroform fraction using silica gel 
(100-200 mesh) column chromatography & Sephadex 
(LH-20). It was eluted in 15% of ethyl acetate in hexane 
from silica gel column & then purified by LH-20 using 
methanol as eluting solvent. It was then recrystallized 
using cyclohexane. The structure of compound GG-02 
was characterized as Hispaglabridin B by comparison of 
its spectral data with reported data. 
 
 
Figure 8: HPTLC graph of Trace 5-8 
 
White amorphous compound (100 mg) isolated from hexane fraction using silica gel (100-200 mesh) column 
chromatography & eluted in 2-4% of ethyl acetate in hexane. 
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Figure 9: HPTLC graph of Trace 8-12 
White needle shaped crystalline compound (50 mg) 
isolated from chloroform fraction using silica gel (100-
200 mesh) column chromatography & Sephadex (LH-
20). It was eluted in 15% of ethyl acetate in hexane from 
silica gel column & then purified by LH-20 using 
methanol as eluting solvent. It was then recrystallized 
using cyclohexane. The structure of compound GG-03 
was characterized as 4-O-Metylglabridin by comparison 
of its spectral data with reported data. 
 
Figure 10: Spectrum scan results 
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The spctra of HPTLC is shown in the graph, the density of compound was measured by absorbance of each 
compo0unds then calculated individually as given in the calculation. 
 
Figure 11: Summary Report of HPTLC graph 
In the given graph summary of all compounds high pressure thin layer chromatographic revaluation is given. The 
compound which showed best result may be used in daily routine life. 
 
Figure 12: HPTLC Images 
In the given diagram the high pressure thin layered chromatographic images of each compound is given to compare the 
each isolated compounds. 
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